Head & Neck Cancers | Specialty

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer.

Dabrafenib/Trametinib Combo Nears 70% Response in Thyroid Cancer

January 4th 2018

Nearly 7 in 10 patients with locally advanced or metastatic BRAF V600E–mutated anaplastic thyroid cancer responded to treatment with the combination of the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib.

Dr. Cohen on Immunotherapy Combinations in Head and Neck Cancer

December 22nd 2017

Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses immunotherapy combinations in head and neck cancer.

Evolving Role of Surgery in Multidisciplinary Care for Head and Neck Cancer

December 18th 2017

Joseph A. Califano, MD, discusses how surgery factors into modern multidisciplinary care for patients with head and neck cancer.

Thyroid Cancer Landscape Advancing to Include Novel Surgical Techniques

December 16th 2017

Michael Bouvet, MD, highlights the evolving surgical options in the thyroid cancer field

Multidisciplinary Care Critical in Head and Neck Cancer

December 15th 2017

Assuntina G. Sacco, MD, discusses the importance of multidisciplinary care for patients with head and neck cancer.

Study Finds Significant Survival Disparities in HPV-related Cancer

December 9th 2017

Younger patients, women, and white patients with HPV-related cancers had superior survival at 5 years, indicating that increased HPV vaccination and better access to cancer screening and treatment are likely needed to reduce survival disparities

Dr. Bouvet Discusses the Diagnosis of Thyroid Cancer

December 8th 2017

Michael Bouvet, MD, professor of surgery, University of California, San Diego, discusses the diagnosis of thyroid cancer.

Number of Sexual Partners, Smoking Identified as Risk Factors for Oropharyngeal Cancer

December 8th 2017

While the incidence of HPV-related oropharyngeal cancer is increasing, the risk for developing the disease remains low for most people.

Dr. Daniels on Immunotherapy in Head and Neck Cancer

December 7th 2017

Gregory A. Daniels, MD, PhD, medical oncologist, associate professor of medicine, UC San Diego Health, discusses the role of immunotherapy for patients with head and neck cancer.

Dr. Califano on the Role of Multidisciplinary Care for Head and Neck Cancer

November 28th 2017

Joseph A. Califano, MD, professor of surgery, University of California, San Diego, discusses the role of multidisciplinary care for patients with head and neck cancer.

Expert Calls for a Change in the Staging of HNSCC

November 21st 2017

Loren K. Mell, MD, explains his research for risk-stratifying patients with head and neck cancer.

Dr. Gold on Approaching Patients with HPV-Positive Head and Neck Cancer

November 14th 2017

Kathryn A. Gold, MD, medical oncologist, associate professor of medicine, UC San Diego Heath, discusses approaching patients with HPV-positive head and neck cancer.

Dr. Mell on Risk Stratification for Head and Neck Cancer

November 8th 2017

Loren K. Mell, MD, assistant professor, Department of Radiation Medicine and Applied Sciences, University of California, San Diego School of Medicine, discusses risk stratification for patients with head and neck cancer.

Dr. Cohen on the Quality of Life in Head and Neck Cancer

November 7th 2017

Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses the unmet need facing the quality of life for patients with head and neck cancer.

Dr. Bouvet on Remaining Challenges With Thyroid Cancer Surgery

November 3rd 2017

Michael Bouvet, MD, professor of surgery, University of California, San Diego, discusses the remaining challenges with thyroid cancer surgery.

Dr. Sacco on Upfront Treatments for Head and Neck Cancer

November 3rd 2017

Assuntina G. Sacco, MD, assistant professor of medicine, medical oncologist, UC San Diego Health, discusses upfront treatment for patients with head and neck cancer.

Dr. Califano on the Future of Surgery in Head and Neck Cancer

November 3rd 2017

Joseph A. Califano, MD, professor of surgery, University of California, San Diego, discusses the future of surgery in head and neck cancer.

Expert Differentiates Carcinogen-Induced and Virally Associated HNSCC

October 30th 2017

Kathryn A. Gold, MD, discusses HPV status and prognosis, as well recognizing risk factors of virally-associated head and neck squamous cell carcinoma.

Immunotherapy, New Targeted Approaches Explored in Thyroid Cancer

October 30th 2017

Gregory Daniels, MD, PhD, discusses the current treatment landscape of thyroid cancer and the development of immunotherapy for patients with this disease.

Dr. Daniels Discusses Treatment Options in Thyroid Cancer

October 27th 2017

Gregory A. Daniels, MD, PhD, medical oncologist, associate professor of medicine, UC San Diego Health, discusses treatment options for patients with thyroid cancer.